Pages that link to "Q47574265"
Jump to navigation
Jump to search
The following pages link to NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017. (Q47574265):
Displaying 50 items.
- Cost-effectiveness Analysis of Nivolumab for Treatment of Platinum-Resistant Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. (Q46004078) (← links)
- Association of Quantitative Metastatic Lymph Node Burden With Survival in Hypopharyngeal and Laryngeal Cancer. (Q46005654) (← links)
- Epidemiological and treatment-related factors contribute to improved outcome of oropharyngeal squamous cell carcinoma in Finland. (Q47214971) (← links)
- Efficacy and safety of anti-EGFR agents administered concurrently with standard therapies for patients with head and neck squamous cell carcinoma: a systematic review and meta-analysis of randomized controlled trials. (Q48294854) (← links)
- Methylated genomic loci encoding microRNA as a biomarker panel in tissue and saliva for head and neck squamous cell carcinoma. (Q52595140) (← links)
- Visualizing the effects of metformin on tumor growth, vascularity, and metabolism in head and neck cancer. (Q52639033) (← links)
- Application of molecular targeted therapies in the treatment of head and neck squamous cell carcinoma. (Q54979771) (← links)
- Contemporary Management of Benign and Malignant Parotid Tumors. (Q55378954) (← links)
- Optimal regimen of cisplatin in squamous cell carcinoma of head and neck yet to be determined. (Q55712493) (← links)
- The role of p16 as a biomarker in nonoropharyngeal head and neck cancer (Q57117183) (← links)
- Prognostic value of primary tumor surgery in minor salivary-gland carcinoma patients with distant metastases at diagnosis: first evidence from a SEER-based study (Q57175202) (← links)
- Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of veterans health affairs data (Q57807621) (← links)
- Persistent Head and Neck Cancer Following First-Line Treatment (Q58613795) (← links)
- Evaluation of pemetrexed and etoposide as therapeutic regimens for human papillomavirus-positive oral and oropharyngeal cancer (Q59357202) (← links)
- Relationship Between p16 Expression and Prognosis in Patients with Oropharyngeal Cancer Undergoing Surgery (Q59358242) (← links)
- Crosstalk Between PD-1/PD-L1 Blockade and Its Combinatorial Therapies in Tumor Immune Microenvironment: A Focus on HNSCC (Q59813521) (← links)
- Inactivation of RUNX3 protein expression in tongue squamous cell carcinoma and its association with clinicopathological characteristics (Q60928812) (← links)
- Polymorphisms in rs17655 and rs735482 Genes Associated with the Survival of Male Patients with Postoperative Oral Squamous Cell Carcinoma Treated with Adjuvant Concurrent Chemoradiotherapy (Q61809903) (← links)
- A novel integrated platform for the identification of surgical margins in oral squamous cell carcinoma: results from a prospective single-institution series (Q64052208) (← links)
- The association between dental therapy timelines and osteoradionecrosis: a nationwide population-based cohort study (Q64108581) (← links)
- Sinosanal undifferentiated carcinoma with liver metastasis: surgical management (Q64255238) (← links)
- Computer-assisted image analysis of the tumor microenvironment on an oral tongue squamous cell carcinoma tissue microarray (Q64286357) (← links)
- Current Role of Surgery in the Management of Oropharyngeal Cancer. (Q64963561) (← links)
- Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma (Q87951509) (← links)
- Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck (Q88059301) (← links)
- Vitamin D intake and survival and recurrence in head and neck cancer patients (Q88657613) (← links)
- The role of adjuvant treatment in early-stage oral cavity squamous cell carcinoma: An international collaborative study (Q88661837) (← links)
- Laser debulking or tracheotomy in airway management prior to total laryngectomy for T4a laryngeal cancer (Q88733187) (← links)
- Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers (Q88923213) (← links)
- AHNS Series: Do you know your guidelines? Principles for treatment of cancer of the paranasal sinuses: A review of the National Comprehensive Cancer Network guidelines (Q89305714) (← links)
- Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma (Q90059007) (← links)
- Real-world treatment patterns for patients with metastatic head and neck squamous cell carcinoma treated with immuno-oncology therapy (Q90154661) (← links)
- Preoperative Sonographic and Clinicopathological Predictors for Solitary Lateral Neck Node Metastasis in Papillary Thyroid Carcinoma: A Retrospective Study (Q90636860) (← links)
- Response Rate of Cisplatin Plus Docetaxel as Primary Treatment in Locally Advanced Head and Neck Carcinoma (Squamous Cell Types) (Q90655039) (← links)
- Metabolic tumor volume and total lesion glycolysis predict tumor progression and survival after salvage surgery for recurrent oral cavity squamous cell carcinoma (Q91190916) (← links)
- Marked responses to pemetrexed chemotherapy for metastatic adenocarcinoma of the parotid gland: Case series (Q91301151) (← links)
- Polymorphisms of Mismatch Repair Pathway Genes Predict Clinical Outcomes in Oral Squamous Cell Carcinoma Patients Receiving Adjuvant Concurrent Chemoradiotherapy (Q91614210) (← links)
- Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck (Q91620241) (← links)
- Intensive Local Radiotherapy Is Associated With Better Local Control and Prolonged Survival in Bone-Metastatic Nasopharyngeal Carcinoma Patients (Q91713556) (← links)
- Competing Morbidities In Advanced Head And Neck Squamous Cell Carcinoma Concurrent Chemoradiotherapy: A Strong Implication Of A Multidisciplinary Team Approach (Q91830094) (← links)
- The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC) (Q91895909) (← links)
- Fluorouracil sensitivity in a head and neck squamous cell carcinoma with a somatic DPYD structural variant (Q92217710) (← links)
- Transoral robotic surgery for head and neck malignancies: Imaging features in presurgical workup (Q92337692) (← links)
- Impact and Relevance of the Unfolded Protein Response in HNSCC (Q92445240) (← links)
- Two enemies, one fight: An update of oral cancer in patients with Fanconi anemia (Q92473866) (← links)
- Safety of esophagogastroduodenoscopy-guided forceps biopsy and the feasibility of esophagogastroduodenoscopy for evaluation of hypopharyngeal cancer (Q92504638) (← links)
- Challenges of Hearing Rehabilitation after Radiation and Chemotherapy (Q92734282) (← links)
- A Retrospective Study of The Prognostic Significance of Preoperative Plasma Fibrinogen, Mean Platelet Volume, and the Neutrophil-to-Lymphocyte Ratio in Patients with Laryngeal Squamous Cell Carcinoma (Q92833965) (← links)
- Surgical rescue for persistent head and neck cancer after first-line treatment (Q92946549) (← links)
- Pattern of planned systemic therapy usage in newly diagnosed, nonmetastatic squamous cell carcinoma of the head and neck in a commercially insured population in the United States (Q93026818) (← links)